Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2022-04-07 20:58:482022-04-07 20:58:48Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.